Elsevier Announces New Clinical Solutions Group Within The Health Sciences Division
Randy Charles leads group designed to increase the pace of implementation of clinical research findings
Philadelphia, October 23, 2007 – Elsevier, the world's leading publisher of science and health information, has announced the formation of a new Clinical Solutions group within its Health Sciences division. The new group is structured from the perspective of the clinician-customer and combines the company’s journals, books and clinical decision support tools to address the needs of medical customers, including medical researchers, practitioners, providers and payors.
Studies have shown that it takes as much as 17 years to translate the findings from research studies into practice. By connecting the company’s journal and periodicals content with its electronic tools, Elsevier hopes to increase the pace of physician adoption of research findings and improve outcomes in health.
"Combining our print and electronic divisions, our periodical and book divisions and evidence and experience based content will fuel innovation through improved coordination," said Randy Charles Executive Vice President, Clinical Solutions, and previously global head of marketing for Elsevier Health Sciences. "We're now able to provide enhanced content delivered through improved work flow tools to health care professionals, medical students, residents, clinicians, researchers and authors, in all phases of their careers."
Reporting to Randy are: Russ Thomas, CEO Gold Standard; Linda Belfus, Senior Vice President for U.S. Medicine; Glen Campbell, Senior Vice President, U.S. Health Sciences Journals; Jonathan Teich, Chief Medical Informatics Officer; John Schrefer, Vice President, Continuity (Clinics of North America) and Mike Takats, Vice President MDConsult.
"This new customer-focused structure allows us to better understand the true needs of our customer segments and increase our effectiveness," said Brian Nairn, CEO, Elsevier Health Sciences. "We can now deploy our assets to achieve optimal growth and profitability goal while surpassing the expectations of customers and end users."
Some of the leading brands and products now coordinated within the Clinical Solutions group include:
Clinical Decision and Reference Support Products: MDConsult, FirstConsult, Clinical Pharmacology, EmpoweRx and ProceduresConsult.
Medical Periodicals: 200+ medical journals, including The American Journal of Medicine and Journal of the American College of Cardiology; and The Clinics of North America.
Clinical References and Textbooks: All Mosby and Saunders medical titles, including Braunwald’s Heart Disease, Cecil’s Textbook of Medicine, and Gray’s Anatomy.
The other groups within the Health Sciences Division are Nursing and Health Professions, Pharma Solutions and International.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
+1 212 462 1912